Clinical Trial Update: Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating vadadustat for maintenance treatment of anemia in dialysis-dependent CKD completed with posted results in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Dialysis-dependent Chronic Kidney Disease

Drugs mentioned

• Vadadustat (vadadustat)

Snippet

Sponsor: Akebia Therapeutics | Conditions: Anemia, Dialysis-Dependent Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2022-06-28